Loading...
Loading...
India's empagliflozin imports from BRAZIL total $2.3M across 38 shipments from 15 foreign suppliers. DERMA & DERMO COM. PRODS. DERM. FARM. LTDA (AMHO) leads with $2.2M in import value; the top 5 suppliers together control 99.3% of this origin. Leading Indian buyers include MSN LABORATORIES PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for empagliflozin — a diversified sourcing base with multiple active suppliers from BRAZIL.

DERMA & DERMO COM. PRODS. DERM. FARM. LTDA (AMHO) is the leading Empagliflozin supplier from BRAZIL to India, with import value of $2.2M across 4 shipments. The top 5 suppliers — DERMA & DERMO COM. PRODS. DERM. FARM. LTDA (AMHO), DERMA & DERMO COMERCIO DE PRODUTOS DERMATOLOGICOS, M/S. DERMA & DERMO COM.PRODS.DERM.F, DERMA & DERMO COMRCIO DE PRODUTOS DERMATOLOGICOS E, DERMA DERMO COMERCIO DE PRODUTOS DERMATOLOGICOS — collectively account for 99.3% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | DERMA & DERMO COM. PRODS. DERM. FARM. LTDA (AMHO) | $2.2M | 4 | 93.3% |
| 2 | DERMA & DERMO COMERCIO DE PRODUTOS DERMATOLOGICOS | $113.7K | 6 | 4.8% |
| 3 | M/S. DERMA & DERMO COM.PRODS.DERM.F | $10.4K | 2 | 0.4% |
| 4 | DERMA & DERMO COMRCIO DE PRODUTOS DERMATOLOGICOS E | $10.3K | 1 | 0.4% |
| 5 | DERMA DERMO COMERCIO DE PRODUTOS DERMATOLOGICOS | $5.3K | 1 | 0.2% |
| 6 | New Life Medicals (USA) Inc. | $4.3K | 2 | 0.2% |
| 7 | NewLife Medicals (USA). Inc. | $3.2K | 2 | 0.1% |
| 8 | ZYDUS NIKKHO FARMACEUTICA LTDA | $3.1K | 4 | 0.1% |
| 9 | BILCARE GCS INC | $2.2K | 2 | 0.1% |
| 10 | NEWLIFE MEDICALS (USA). INC. | $1.6K | 2 | 0.1% |
| 11 | DR. REDDYS FARMACEUTICA DO BRASIL LTDA | $644 | 2 | 0.0% |
| 12 | ZYDUS NIKKHO FARMACEUTICAL LTDA | $572 | 1 | 0.0% |
| 13 | CAMBER FARMACEUTICA LTDA, | $560 | 1 | 0.0% |
| 14 | BIOAGRI LABORATORIOS LIMITEDA. | $466 | 1 | 0.0% |
| 15 | CAMBER FARMACEUTICAL LTD | $141 | 3 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | MSN LABORATORIES PRIVATE LIMITED | $2.2M | 2 | 93.2% |
| 2 | ALEMBIC PHARMACEUTICALS LIMITED | $113.2K | 6 | 4.8% |
| 3 | MEDREICH LIMITED | $10.4K | 2 | 0.4% |
| 4 | ADMERUS BIOSCIENCES PVT LTD | $10.3K | 1 | 0.4% |
| 5 | INVENTIA HEALTHCARE LIMITED | $10.2K | 6 | 0.4% |
| 6 | CLIANTHA RESEARCH LIMITED | $5.9K | 2 | 0.2% |
| 7 | LAMBDA THERAPEUTIC RESEARCH LIMITED | $3.6K | 1 | 0.2% |
| 8 | ZYDUS HEALTHCARE LIMITED | $2.0K | 2 | 0.1% |
| 9 | COPMED PHARMACEUTICALS PRIVATE LIMITED | $1.6K | 2 | 0.1% |
| 10 | ZYDUS LIFESCIENCES LIMITED | $1.1K | 2 | 0.0% |
| 11 | CLIANS LABS PRIVATE LIMITED | $845 | 2 | 0.0% |
| 12 | DR.REDDY'S LABORATORIES LTD | $644 | 2 | 0.0% |
| 13 | VEEDA CLINICAL RESEARCH LIMITED | $466 | 1 | 0.0% |
| 14 | HETERO LABS LIMITED | $231 | 5 | 0.0% |
| 15 | DR REDDYS LABORATORIES LIMITED | $10 | 2 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Empagliflozin suppliers from BRAZIL to India include DERMA & DERMO COM. PRODS. DERM. FARM. LTDA (AMHO), DERMA & DERMO COMERCIO DE PRODUTOS DERMATOLOGICOS, M/S. DERMA & DERMO COM.PRODS.DERM.F. The leading supplier is DERMA & DERMO COM. PRODS. DERM. FARM. LTDA (AMHO) with import value of $2.2M USD across 4 shipments. India imported Empagliflozin worth $2.3M USD from BRAZIL in total across 38 shipments.
India imported Empagliflozin worth $2.3M USD from BRAZIL across 38 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Empagliflozin sourced from BRAZIL include MSN LABORATORIES PRIVATE LIMITED, ALEMBIC PHARMACEUTICALS LIMITED, MEDREICH LIMITED. The largest buyer is MSN LABORATORIES PRIVATE LIMITED with $2.2M in imports across 2 shipments.
The total value of Empagliflozin imports from BRAZIL to India is $2.3M USD, across 38 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
38 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists